Drug application
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE (BACITRACIN ZINC, HYDROCORTISONE ACETATE, NEOMYCIN SULFATE and 1 more)
Drugs@FDA ANDA 062166 · PADAGIS US
Key facts
| Drug name | BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE |
|---|---|
| Active ingredients | BACITRACIN ZINC, HYDROCORTISONE ACETATE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE |
| Application type | ANDA |
| Application number | 062166 |
| Company | PADAGIS US |
| Dosage forms | OINTMENT, OPHTHALMIC |
| Strength | 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Apr 14, 1981 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.